Preeclampsia: what we know and what we do not know

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Cardiovascular Pathophysiology

Background:

• Preeclampsia poses significant risks to maternal and infant health.
• Current understanding views preeclampsia as a two-stage disorder: placental issues and maternal systemic disorder.
• The precise linkage between these stages and the maternal syndrome's development remains unclear.

Purpose of the Study:

• To explore the hypothesis that reduced placental perfusion interacts with maternal constitutional factors to cause preeclampsia.
• To investigate the potential role of oxidative stress in linking preeclampsia's two stages.
• To examine the common pathophysiological pathways between preeclampsia and atherosclerosis.

Main Methods:

• Review of current literature on preeclampsia pathophysiology.
• Analysis of similarities in risk factors and metabolic alterations between preeclampsia and atherosclerosis.
• Postulation of oxidative stress as a key mediator.

Main Results:

• Reduced placental perfusion alone does not fully explain preeclampsia pathophysiology.
• Conditions with reduced perfusion (e.g., intrauterine growth restriction) do not always result in the maternal syndrome.
• Oxidative stress is proposed as the mechanism causing endothelial dysfunction, linking placental and maternal stages.

Conclusions:

• Preeclampsia likely results from an interaction between reduced placental perfusion and maternal factors.
• Oxidative stress is a proposed unifying mechanism for endothelial dysfunction in preeclampsia.
• Further research into oxidative stress could illuminate preeclampsia's pathophysiology and inform treatment strategies.